PCN8 REAL LIFE OUTCOMES IN 1ST LINE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)- A PILOT STUDY IN FRANCE AND GERMANY ANALYSING BEVACIZUMAB-BASED VERSUS NON-BEVACIZUMAB-BASED TREATMENTS
Abstract
Authors
H.G. Bischoff C. Chouaid A. Vergnenegre D.F. Heigener G. Taylor-Stokes A. Roughley S. Walzer